Speaker illustration

Professor Phil Mc Ewan

Swansea University, Swansea (United Kingdom of Great Britain & Northern Ireland)

Phil is a mathematician who gained his PhD at the School of Mathematics, Cardiff University. His work here involved the development of deterministic and stochastic compartmental simulation models for use with back projection methods for quantifying the incidence of HIV infection. He was then employed as a research associate at the School investigating the use and validity of cardiovascular risk functions in type II diabetes. For twelve years, Phil worked as Director and Senior Research Mathematician at Cardiff Research Consortium. Phil’s technical expertise lies in simulation modelling and multivariate statistical data analysis, whilst his primary academic interest is efficient simulation methods and methods for the reduction of variance in simulation models. Phil is currently Professor and Technical Director at the Centre for Health Economics, Swansea University and Managing Director of HEOR Ltd, working mainly in the area of HIV, oncology, diabetes and infectious disease modelling.

Assessing the impact of cardiovascular events on health-related quality of life outcomes in DAPA-HF

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Chronic heart failure e-posters

Thumbnail

Evaluating the key predictors of health-related quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Chronic heart failure e-posters

Thumbnail

AFFIRM-AHF Cost-Effectiveness Modelling Results in 4 Countries (US, UK, CH & IT).

Event: Heart Failure 2021 Online Congress

Topic: Chronic Heart Failure

Session: Clinical, Quality of Life and Cost-Effectiveness learnings from the AFFIRM-AHF Clinical Trial

Thumbnail

AFFIRM-AHF-based multinational cost-effectiveness analysis of intravenous ferric carboxymaltose for the treatment of iron deficiency in an acute heart failure setting

Event: Heart Failure 2021 Online Congress

Topic: Pharmacotherapy

Session: Late-Breaking Trials 2

Thumbnail

Budget impact evaluation of the DAPA-HF trial: is dapagliflozin cost-saving for the treatment of heart failure with reduced ejection fraction?

Event: Heart Failure 2021 Online Congress

Topic: Cardiovascular Epidemiology

Session: ePoster session

Thumbnail

The relationship between duration of heart failure, serum potassium concentration and adverse clinical outcomes

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: The Different and Changing Faces of Heart Failure

Thumbnail

Estimating the burden of hyperkalaemia in the UK in high-risk patient populations

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology

Session: Risk Factors and Prevention ePosters

Thumbnail

Assessing the relationship between serum potassium variability and the risk of hyperkalaemia and adverse clinical outcomes

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology

Session: Risk Factors and Prevention ePosters

Thumbnail

This platform is supported by

logo Novo Nordisk